BHP annonce la conclusion d'accords de transport ferroviaire avec le CN et le CPKC pour acheminer la potasse de Jansen vers ses clients internationaux

Health Catalyst to Divest Vitalware for $147 Million, Accelerating Strategic Transformation

PineX Capital Expands Into the UK as German Prop Firm Targets One of the World's Largest Trading Markets

Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Spyre Therapeutics Announces Grants of Inducement Awards

B2B Marketing Services, Defined: What a Mid-Market and Enterprise Engagement Includes

Mortgage Rates Decline

PatentVest Publishes New IP Legal Insights Article Examining Why Patent Prosecution Is Ready for AI

Enterprise SEO for B2B: Organic Authority at Scale in the AI Era

Trust Stamp makes first LLM-focused AI Patent filing for Medical Diagnosis Assurance

Best B2B Marketing Agencies: The Criteria That Separate the Category Leaders

DeFi Development Corp. to Host X Spaces Event: “DFDV March 2026 Recap & AMA + FY 2025 Earnings Breakdown”

KBR’s Mission Technology Solutions Supports NASA’s Artemis II Mission as Astronauts Embark on Historic Return to the Moon

Media Advisory-Axonius Adapt 2026: Closing the Cybersecurity Actionability Gap with Asset Intelligence in the AI Age

SEDA Expands Its Economic Sanctions, AML, and Financial Crime Compliance Expertise with the Addition of Amber Vitale

Simple, Convenient, Time-Saving Snacks for Busy Families

Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP

VolitionRx Announces Pricing of $4.6 Million Public Offering

FSK Investors Have Opportunity to Lead FS KKR Capital Corp. Securities Fraud Lawsuit

Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications

Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026

AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS

Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes

CERAVE VÍTA NA PRVÝCH GLOBÁLNYCH CENÁCH CERAWARDS VIAC AKO 100 OCENENÝCH TVORCOV OBSAHU Z 22 KRAJÍN

Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health

Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW

Bronstein, Gewirtz & Grossman LLC Urges GeneDx Holdings Corp. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Badger Meter, Inc. Investors to Act: Class Action Filed Alleging Investor Harm